Neupogen (filgrastim)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Neupogen (filgrastim), covering 2010-10-06 to 2010-10-06. Get the full timeline:
Most recent: Clinical Trial Update: AMD3100 (Plerixafor) Added to a Mobilizing Regimen of Granulocyte-colony Stimulating Factor (G-CSF) to Increase the Number of Peripheral Blood Stem Cells (PBSCs) in Patients With Hodgkin's Disease [Phase 2]